Peering Into ZyVersa Therapeutics's Recent Short Interest
Portfolio Pulse from Benzinga Insights
ZyVersa Therapeutics (NYSE:ZVSA) has seen a significant decrease in its short interest, falling 96.61% since its last report. The company now has 15,000 shares sold short, which is 2.06% of its float. This is lower than the peer group average of 3.18%.
May 21, 2024 | 7:15 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
ZyVersa Therapeutics has experienced a significant drop in short interest, now at 2.06% of its float, which is below the peer group average. This could indicate a shift in market sentiment towards a more bullish outlook.
The significant decrease in short interest suggests that fewer investors are betting against the stock, which could indicate a more positive market sentiment. This is further supported by the fact that ZyVersa's short interest is now below the peer group average.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100